Raymond James Financial Services Advisors, Inc. Novavax Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $69.1 Billion
- Q2 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 10,674 shares of NVAX stock, worth $124,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,674Holding current value
$124,138% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$138 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$112 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$73.5 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$70.5 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $910M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...